This study is looking at a drug called Gallium Maltolate for people with recurrent glioblastoma (a type of brain cancer that has come back). Researchers want to see how well Gallium Maltolate gets into the brain and into the tumor. You would take Gallium Maltolate by mouth for about two weeks. After that, you would have a surgical procedure, like a needle biopsy or tumor removal, if your medical team thinks it's necessary. The main goal is to measure differences in the tumor tissue after 3 months. This is a small study, planning to include 8 participants who are at least 18 years old. The current status of the study is unclear.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It is a Phase 0 study, and the planned enrollment is 8 participants.

What's involved

You would take Gallium Maltolate daily for about 14 days. After this, you would have a surgical procedure (needle biopsy or resection) if your clinical team determines it's needed.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, Glioma Tissue Difference, is measured at 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.